News
3 Stocks That Look Just Like Starbucks in 1992
Few companies have experienced the kind of growth Starbucks (NASDAQ: SBUX) has over the past 25 years, and fewer still can proliferate so much to the point where it seems like the coffeeshop is on
3 Stocks That Look Just Like Starbucks in 1992
Few companies have experienced the kind of growth Starbucks (NASDAQ: SBUX) has over the past 25 years, and fewer still can proliferate so much to the point where it seems like the coffeeshop is on
1 Company That Could Eat ExOne's Lunch
No part of the 3-D printing industry has witnessed more interest than metal 3-D printing. Then again, that's what happens when behemoths like General Electric move in. The digital industrial
6 Reasons to Be Hopeful of a Buffalo Wild Wings Stock Turnaround
Nothing seems to be going right at Buffalo Wild Wings (NASDAQ: BWLD), the chicken-wings-and-beer-joint that turned sports bars into an art form. But that doesn't mean there aren't a few reasons to
Here's My Top Stock to Buy in August
Last year, Bank of America/Merrill Lynch released their analysis of an interesting study that examined the performance of growth stocks versus value stocks over the 90-year period from 1926 to 2016
3 Beaten-Up Biotech Stocks: Are They Bargains?
The iShares Nasdaq Biotechnology Index has tacked on a healthy gain of around 15% so far this year, without any help from Celldex Therapeutics, Inc. (NASDAQ: CLDX), Agenus Inc. (NASDAQ: AGEN), or
3 Things That Would Make the iPhone 7s Great
In about a month, Apple (NASDAQ: AAPL) is expected to launch no fewer than three flagship iPhone models. Two of the three are expected to be, in effect, the iPhone 7s and iPhone 7s Plus -- that is
3 Things That Would Make the iPhone 7s Great
In about a month, Apple (NASDAQ: AAPL) is expected to launch no fewer than three flagship iPhone models. Two of the three are expected to be, in effect, the iPhone 7s and iPhone 7s Plus -- that is
3 Things That Would Make the iPhone 7s Great
In about a month, Apple (NASDAQ: AAPL) is expected to launch no fewer than three flagship iPhone models. Two of the three are expected to be, in effect, the iPhone 7s and iPhone 7s Plus -- that is
3 Things That Would Make the iPhone 7s Great
In about a month, Apple (NASDAQ: AAPL) is expected to launch no fewer than three flagship iPhone models. Two of the three are expected to be, in effect, the iPhone 7s and iPhone 7s Plus -- that is
Intel Corporation Kills Microsoft Corporation HoloLens Chip
Technology website AnandTech spotted that Intel (NASDAQ: INTC) issued a product-change notification on Aug. 7, announcing that the Atom x5-Z8100P system-on-a-chip (SoC) used in Microsoft's (NASDAQ:
Intel Corporation Kills Microsoft Corporation HoloLens Chip
Technology website AnandTech spotted that Intel (NASDAQ: INTC) issued a product-change notification on Aug. 7, announcing that the Atom x5-Z8100P system-on-a-chip (SoC) used in Microsoft's (NASDAQ:
Intel Corporation Kills Microsoft Corporation HoloLens Chip
Technology website AnandTech spotted that Intel (NASDAQ: INTC) issued a product-change notification on Aug. 7, announcing that the Atom x5-Z8100P system-on-a-chip (SoC) used in Microsoft's (NASDAQ:
Intel Corporation Kills Microsoft Corporation HoloLens Chip
Technology website AnandTech spotted that Intel (NASDAQ: INTC) issued a product-change notification on Aug. 7, announcing that the Atom x5-Z8100P system-on-a-chip (SoC) used in Microsoft's (NASDAQ:
Can Snap Inc. Stock Bounce Back After Last Week's 10% Drop?
Momentum is still working against Snap, Inc. (NYSE: SNAP) and its shareholders. Shares of Snapchat's parent company tumbled 10.47% last week, falling after posting problematic quarterly results.
Can Snap Inc. Stock Bounce Back After Last Week's 10% Drop?
Momentum is still working against Snap, Inc. (NYSE: SNAP) and its shareholders. Shares of Snapchat's parent company tumbled 10.47% last week, falling after posting problematic quarterly results.
Can Snap Inc. Stock Bounce Back After Last Week's 10% Drop?
Momentum is still working against Snap, Inc. (NYSE: SNAP) and its shareholders. Shares of Snapchat's parent company tumbled 10.47% last week, falling after posting problematic quarterly results.
3 Reasons Netflix Stock Isn't Losing Half Its Value
Shares of Netflix (NASDAQ: NFLX) took a small step back last week, and Jack Hough of Barron's thinks this could be just the beginning. This weekend's Barron's cover story (subscription required) poses
3 Reasons Netflix Stock Isn't Losing Half Its Value
Shares of Netflix (NASDAQ: NFLX) took a small step back last week, and Jack Hough of Barron's thinks this could be just the beginning. This weekend's Barron's cover story (subscription required) poses
Amazon May Have a New Plan to Take on Takeout
Amazon (NASDAQ: AMZN) already challenges supermarkets in a number of ways, including offering grocery delivery in an ever-growing number of markets through its Fresh service. And, of course, the chain
Amazon May Have a New Plan to Take on Takeout
Amazon (NASDAQ: AMZN) already challenges supermarkets in a number of ways, including offering grocery delivery in an ever-growing number of markets through its Fresh service. And, of course, the chain
Amazon May Have a New Plan to Take on Takeout
Amazon (NASDAQ: AMZN) already challenges supermarkets in a number of ways, including offering grocery delivery in an ever-growing number of markets through its Fresh service. And, of course, the chain
The Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think
The marijuana market may be on its way to being worth $25 billion in 2021, and advances in DNA research could lead to next-generation precision medicine worth billions of dollars in annual sales. Yet
The Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think
The marijuana market may be on its way to being worth $25 billion in 2021, and advances in DNA research could lead to next-generation precision medicine worth billions of dollars in annual sales. Yet
The Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think
The marijuana market may be on its way to being worth $25 billion in 2021, and advances in DNA research could lead to next-generation precision medicine worth billions of dollars in annual sales. Yet